Washington D.C. [India], Nov 28 (ANI): The men who have tried all other ways to treat prostate cancer could now count on immunotherapy, claims a recent study.
Washington D.C. [USA], Nov 24 (ANI): Researchers working on Artificial Intelligence has hit another milestone as they have found a way to predict if a lung-cancer patient can be benefitted from expensive immunotherapy.
Washington D.C. [USA], Sept 29 (ANI): In a new trial, researchers have discovered that a combination of two immunotherapy drugs -- ipilimumab and nivolumab - is capable of reversing or preventing the progression of advanced melanoma for five years or more in one in every two patients.
Washington D.C. [USA] Apr 21 (ANI): A recent study has claimed that oral immunotherapy given as routine treatment is safe for preschoolers allergic to peanuts.
Washington D.C. [USA], Apr 1 (ANI): Scientists have found that rare and aggressive neuroendocrine tumours shrink through a combination of two common immunotherapy drugs.
Washington D.C. [USA], Feb 25 (ANI): Dietary consumption of peanut after completing oral immunotherapy (OIT) or sublingual immunotherapy (SLIT) for peanut allergy may actually provide continued protection against accidental exposures to the allergen, according to a new study led by Edwin Kim
Washington D.C. [USA]: A new research, presented by study author Edwin Kim, at the annual Americal Academy of Allergy, Asthma and Immunology (AAAI) conference in San Francisco, found that after completing up to four years of egg oral immunotherapy (eOIT) treatment, certain participants were
Washington D.C. [USA], Feb 18 (ANI): An investigator from Dana-Farber Cancer Institute now says that a combination of two drugs - one of them an immunotherapy agent - could become a new standard, first-line treatment for patients with metastatic kidney cancer. The investigator made the cl
Washington D.C. [USA], Feb 15 (ANI): A research team has now discovered that an immune checkpoint molecule they developed for cancer immunotherapy, also protects against future development of multiple types of cancer when administered by itself.
Washington D.C. [USA], Dec 11 (ANI): According to a recent study, a slow-growing brain tumor in patients affected by neurofibromatosis type 1 (NF1) may be vulnerable to immunotherapy, which helps to boost the immune system in fighting cancer.
Brisbane [Australia], Nov 20 (ANI): A world-first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has found that it improved symptoms and quality of life for the majority of patients.